Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Inhibitors of factor Xa described in patent by Cor Therapeutics

Feb. 4, 2002

Factor Xa-inhibitory lactams disclosed by Bristol-Myers Squibb

Feb. 4, 2002

Bivalirudin reduces both thrombotic and bleeding complications in acute coronary syndromes

Feb. 4, 2002

Integrin receptor inhibitors identified at Merck KGaA

Feb. 1, 2002

Schering-Plough discloses use and preparation of thrombin and CB2 receptor antagonists

Feb. 1, 2002

Aventis synthesizes urea and thiourea derivatives as inhibitors of factor VIIa

Jan. 22, 2002

Anticoagulants derived from phenylglycine at Roche

Jan. 18, 2002

CSL obtains marketing and distribution license to Angiomax in Australia

Jan. 10, 2002

Emisphere completes enrollment in PROTECT trial of oral heparin

Jan. 9, 2002

Cor Therapeutics reports new series of platelet ADP receptor inhibitors

Jan. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...